Group 1 - The 2025 China Obesity Conference was held from August 15 to August 17 at the National Convention Center in Beijing, focusing on the increasing challenges of metabolic diseases and the development of obesity management through evidence-based medicine [1] - Eli Lilly actively supported the national weight management initiative by organizing a public walking event titled "Less Resistance, Easier Weight Loss," engaging hospitals, associations, the public, and media to create a strong social coalition for establishing a weight management ecosystem [1][7] - During the conference, Eli Lilly hosted a special session on "Multimodal Treatment of Obesity Surgery and Medications," connecting international experts with Chinese doctors for in-depth discussions based on new data, replicating the academic exchange atmosphere of the European Obesity Congress (ECO) [3] Group 2 - The ScopeSchool, organized by the World Obesity Federation (WOF) during the conference, featured around 300 doctors who gained cutting-edge knowledge in clinical management through multidisciplinary exchanges and case discussions, receiving international obesity training certificates from WOF [4] - Eli Lilly held a symposium titled "Reshaping the New Landscape of Obesity Treatment: Adult Long-term Weight Management," gathering top experts in obesity treatment to discuss the SURMOUNT-5 head-to-head study published in the New England Journal of Medicine and the latest evidence on obesity with moderate to severe obstructive sleep apnea [6] - The "Focus on Weight Management" exhibition showcased Eli Lilly's global scientific advancements and treatment concepts, aiming to bridge the gap between research and practical application while enhancing collaboration between academia and industry to accelerate the standardization of obesity treatment in China [6]
礼来亮相2025中国肥胖大会 与体重管理年行动同频共振